Vietnam Investment Review on MSN
Lynk Pharma reports positive phase III results for Zemprocitinib in RA
HANGZHOU, China, SHANGHAI and BOSTON, Jan. 12, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical stage innovative drug development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback